Exelixis
EXEL
#1645
Rank
NZ$16.77 B
Marketcap
$60.89
Share price
0.11%
Change (1 day)
59.82%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company